Forgot your password?
Median overall survival (OS) for patients with advanced melanoma was 72.1 months when they received nivolumab in combination with ipilimumab.
IL-17A inhibitor has been cleared in the US to treat plaque psoriasis in certain patients aged six years and older
Predictive biomarkers could be used to personalise treatment for patients
Skin therapist takes on a five-day trek across the Sahara Dessert with the hope of raising £2,500 for the British Skin Foundation.
Study participants reported improvements in scaling, thickness and itching
The Academy has held a roundtable discussion to assess the effectiveness of the European Commission’s Beating Cancer Plan and identify joint recommendations on preventing skin cancer and melanoma
Data published in The Lancet show that the Trispecific Nanobody “totally clears skin in almost 6 out of 10 patients” with moderate to severe psoriasis
The investigational selective tyrosine kinase 2 (TYK2) inhibitor deucravacitinib showed superiority over apremilast in two Phase III psoriasis trials.
British Association of Dermatologists urges public to check for signs of skin cancer following ‘concerning’ decrease
Nomination closing date has been extended to 3 May